Preferred Stock Dividends Paid (Annual)

Preferred Stock Dividends Paid: The cash outflow for dividends paid on a company's preferred stock.

Caris Life Sciences,ï¿½Inc. (CAI) Preferred Stock Dividends Paid data is not available.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$812.03M
Net Income	$-537.96M
Cost of Goods Sold	$272.87M
Gross Profit	$539.17M
Operating Expenses	$766.92M
Operating Income	$45.11M
Non-Operating Income/Expense	$-113.20M
Pre-Tax Income	$-68.09M
Normalized Pre-Tax Income	$-68.09M
Income after Taxes	$-68.09M
Income from Continuous Operations	$-68.09M
Consolidated Net Income/Loss	$-68.09M
Normalized Income after Taxes	$-68.09M
EBIT	$45.11M
EBITDA	$80.50M
Weighted-Average Shares Outstanding (Basic)	167.21M
Weighted-Average Shares Outstanding (Diluted)	167.21M
Earnings per Share (EPS) (Basic)	$-3.22
Earnings per Share (EPS) (Diluted)	$-3.22
Balance Sheet Financials
Current Assets	$997.80M
Property, Plant, and Equipment	$63.17M
Long-Term Assets	$127.86M
Total Assets	$1.13B
Current Liabilities	$127.14M
Long-Term Debt	$378.82M
Long-Term Liabilities	$421.21M
Total Liabilities	$548.36M
Common Equity	$577.31M
Tangible Shareholders Equity	$557.96M
Shareholders Equity	$577.31M
Common Shares Outstanding	282.53M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$83.16M
Cash Flow from Investing Activities	$-16.26M
Cash Flow from Financial Activities	$664.99M
Beginning Cash	$68.03M
End Cash	$800.04M
Increase/Decrease in Cash	$732.01M
Stock-Based Compensation	$70.01M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	7.85
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.40
Debt to Equity Ratio	0.66
Gross Margin	66.40%
Operating Margin	5.56%
EBIT Margin	5.56%
EBITDA Margin	9.91%
Pre-Tax Profit Margin	-8.38%
Profit Margin	-66.25%
Free Cash Flow	$66.89M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.72
Inventory Turnover	4.29
Receiveable Turnover	7.24
Days Sales in Receivables	50.41
Return on Equity	-11.79%
Return on Tangible Equity	-12.20%
Return on Assets	-6.05%
Return on Investments	-7.12%
Book Value Per Share	$2.04
Free Cash Flow per Share	$0.40
Operating Cash Flow per Share	$0.50

Data from Zacks Investment Research, Inc.